Clinical Trials Browser

Phase 2 × Infiltrating Bladder Urothelial Carcinoma × Radiation Dose Hypofractionation × Clear all

NCT03419130 2018-12-07

Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer

Phase 2 Withdrawn

Infiltrating Bladder Urothelial Carcinoma